What is CAR-T therapy and how is advancing the fight against cancer? You won’t want to miss out on this week’s discussion bringing together curious minds around cutting-edge Life Science research.
Join us for Open Journal Club, a collaboration with CIC Labs and Venture Café, an in-person monthly discussion series that tackles the most recent research papers in the Life Sciences. Our goal is to bring together various perspectives to leverage our collective expertise to advance discoveries and knowledge in the Life Sciences.
We’re kicking things off with a deep dive into Chimeric Antigen Receptors. What are they and how are they used in the fight against cancer?
Josh Seoane will be facilitating a lively discussion on some of the latest work on CAR T in “CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy” from The Journal of Experimental & Clinical Cancer Research.
This month’s article citation:
Pan, K., Farrukh, H., Chittepu, V.C.S.R. et al. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. J Exp Clin Cancer Res 41, 119 (2022). https://doi.org/10.1186/s13046-022-02327-z